Amgen Announces the Formation of Amgen Ventures
Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics
15-Nov-2004 -
Amgen Inc., the world's largest biotechnology company, announced the formation of Amgen Ventures, a corporate venture capital fund designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen's ...
biotechnology
collaborations
Formation
+3